Analysts think LAB stock price could increase by 111%
Mar 13, 2025, 11:25 AM
0.00%
What does LAB do
Standard BioTools, headquartered in South San Francisco, offers biotechnology tools and services for clinical research, focusing on proteomics and genomics with 534 employees since its IPO in 2011. The company provides insights into health and disease using advanced technologies for diverse applications in translational and clinical research.
3 analysts think LAB stock price will increase by 110.65%. The current median analyst target is $2.42 compared to a current stock price of $1.15. The lowest analysts target is $2.27 and the highest analyst target is $2.63.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.